1. Home
  2. BNTC vs SWBI Comparison

BNTC vs SWBI Comparison

Compare BNTC & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • SWBI
  • Stock Information
  • Founded
  • BNTC 1995
  • SWBI 1852
  • Country
  • BNTC United States
  • SWBI United States
  • Employees
  • BNTC 16
  • SWBI N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • SWBI Ordnance And Accessories
  • Sector
  • BNTC Health Care
  • SWBI Industrials
  • Exchange
  • BNTC Nasdaq
  • SWBI Nasdaq
  • Market Cap
  • BNTC 322.6M
  • SWBI 397.3M
  • IPO Year
  • BNTC N/A
  • SWBI N/A
  • Fundamental
  • Price
  • BNTC $13.75
  • SWBI $9.37
  • Analyst Decision
  • BNTC Strong Buy
  • SWBI Buy
  • Analyst Count
  • BNTC 7
  • SWBI 2
  • Target Price
  • BNTC $24.71
  • SWBI $12.75
  • AVG Volume (30 Days)
  • BNTC 64.1K
  • SWBI 502.0K
  • Earning Date
  • BNTC 05-12-2025
  • SWBI 03-06-2025
  • Dividend Yield
  • BNTC N/A
  • SWBI 5.67%
  • EPS Growth
  • BNTC N/A
  • SWBI 16.02
  • EPS
  • BNTC N/A
  • SWBI 0.66
  • Revenue
  • BNTC N/A
  • SWBI $493,046,000.00
  • Revenue This Year
  • BNTC N/A
  • SWBI N/A
  • Revenue Next Year
  • BNTC N/A
  • SWBI $3.86
  • P/E Ratio
  • BNTC N/A
  • SWBI $14.18
  • Revenue Growth
  • BNTC N/A
  • SWBI N/A
  • 52 Week Low
  • BNTC $5.08
  • SWBI $8.38
  • 52 Week High
  • BNTC $16.90
  • SWBI $17.33
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 55.16
  • SWBI 49.37
  • Support Level
  • BNTC $13.26
  • SWBI $8.38
  • Resistance Level
  • BNTC $14.22
  • SWBI $9.46
  • Average True Range (ATR)
  • BNTC 1.37
  • SWBI 0.39
  • MACD
  • BNTC 0.08
  • SWBI 0.07
  • Stochastic Oscillator
  • BNTC 87.27
  • SWBI 87.61

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: